Convention | BIO International San Diego

June 2026

Our CBO, dr. Mike Shaw, recently attended the Bio International Conference in San Diego. During the conference, he spoke with numerous colleagues from the field about our therapeutic programs and the technology Tzu Cancer Therapeutics has developed to study metastasizing biology through the isolation and single-cell DNA and RNA sequencing analysis of Circulating Tumor Cells.

Conversations in San Diego touched on the use of this technology for target identification, clinical efficacy monitoring, and the stratification of clinical trials.

Interested in learning more about our technology or partnership opportunities? Get in touch with Mike Shaw at mike.shaw@tzu.nl.